桂发祥(002820) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥68,519,272.64, a decrease of 39.92% compared to ¥114,052,444.59 in the same period last year[3] - The net profit attributable to shareholders was -¥19,261,561.06, representing a decline of 314.15% from a profit of ¥8,994,229.82 in the previous year[3] - The cash received from sales decreased by 41.36% to ¥76,751,189.70 from ¥130,884,683.42 in the same period last year[8] - Operating profit for the current period is -$19.10 million, compared to a profit of $10.62 million in the previous period[20] - Net profit for the current period is -$19.26 million, a significant decline from a profit of $8.99 million in the previous period[20] - Other comprehensive income after tax for the current period is -$3.45 million, compared to $11.64 million in the previous period[21] Cash Flow and Liquidity - The net cash flow from operating activities was -¥7,127,553.85, down 124.47% from ¥29,122,315.76 in the same period last year[3] - Cash flow from operating activities shows a net outflow of -$7.13 million, compared to a net inflow of $29.12 million in the previous period[24] - Cash and cash equivalents decreased from CNY 263,825,523.16 to CNY 250,881,516.61, a decline of about 4.9%[15] - Cash and cash equivalents at the end of the period are $250.88 million, down from $688.12 million at the end of the previous period[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,126,920,595.42, a decrease of 2.29% from ¥1,153,302,419.55 at the end of the previous year[3] - The company's total liabilities decreased from CNY 99,785,070.31 to CNY 92,668,258.31, representing a reduction of about 7.1%[17] - The total current assets were reported at CNY 743,628,582.39, down from CNY 760,570,798.31, indicating a decrease of approximately 2.2%[15] - The company's inventory decreased from CNY 45,956,234.23 to CNY 42,705,979.06, reflecting a reduction of approximately 7.8%[15] - The non-current assets totaled CNY 383,292,013.03, down from CNY 392,731,621.24, indicating a decrease of approximately 2.5%[16] Research and Development - The company reported a significant increase in R&D expenses, which rose by 42.87% to ¥1,735,398.63 compared to ¥1,214,702.31 in the previous year[7] - Research and development expenses increased to $1.74 million, up from $1.21 million in the previous period, reflecting a focus on innovation[20] Operational Challenges - The company faced significant challenges due to the Omicron variant outbreak, which severely affected sales during the traditional peak season[8] - The company did not open any new direct stores during the reporting period, impacting cash outflows for fixed assets and intangible assets[9] Equity and Earnings - The weighted average return on equity was -1.85%, a decrease of 2.69% from 0.84% in the previous year[3] - The company's retained earnings decreased from CNY 352,600,309.53 to CNY 333,338,748.47, a decline of about 5.5%[17] - The total equity attributable to the parent company decreased from CNY 1,053,517,349.24 to CNY 1,034,252,337.11, reflecting a reduction of approximately 1.8%[17] - The company reported a basic and diluted earnings per share of -$0.10, down from $0.04 in the previous period[21] Operating Costs - Total operating costs for the current period are $90.70 million, down 12.43% from $103.55 million in the previous period[19] - Sales expenses rose to $30.40 million, compared to $29.49 million in the previous period, indicating increased marketing efforts[20]